WMT

WMT developes small molecules for cancer indications by targeting the Warburg Metabolism. The Warburg Metabolism was first described 100 years ago by Otto Heinrich Warburg and the therapeutic approach is based on the fact that many cancer cells predominantly produce their energy through a high rate of glycolysis followed by lactic acid fermentation even in the presence of abundant oxygen. Using this mechanism for the treatment of cancer turns out to be very difficult, as interventions targeted at the sugar metabolism also cause harm to healthy cells. The approach WMT is using offers an improved therapeutic window as opposed to classical cancer medicines.

Info & Contact

Yves Guillermet, CEO
Web:
www.wm-therapeutics.com

Address

WMT AG
Waldhofer Str. 104
69123 Heidelberg

In portfolio

29. Apr 2021

HTGF Manager

 
Dr. Martin Pfister, Principal / Authorized Signatory